Plavix Makers Ordered to Pay Hawaii $834 Million For Alleged ‘Deceptive’ Acts



DOCUMENTS
  • Opinion


HONOLULU — A Hawaii judge has ordered two drug makers to pay the state $834 million for allegedly failing to disclose that their blood-thinning drug Plavix is ineffective in reducing the risk of strokes, blood clots and heart attacks in patients of Asian and Pacific Islander descent.

Bristol-Myers Squibb and Sanofi say they will appeal the ruling, which was issued on Feb. 15 by Hawaii First Circuit Court Judge Dean E. Ochiai following a four-week bench trial that ended on Nov. 20. The drug makers were each ordered to pay $417 million in penalties.

The judge found that the …






UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS



HarrisMartin's MDL Conference: The Current Mass Tort Landscape - Best Management Practices & Updates on Key Litigation

September 28, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS